James M. Bowen

3.7k total citations
145 papers, 2.4k citations indexed

About

James M. Bowen is a scholar working on Genetics, Economics and Econometrics and Epidemiology. According to data from OpenAlex, James M. Bowen has authored 145 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Genetics, 22 papers in Economics and Econometrics and 21 papers in Epidemiology. Recurrent topics in James M. Bowen's work include Virus-based gene therapy research (29 papers), Health Systems, Economic Evaluations, Quality of Life (20 papers) and Animal Virus Infections Studies (18 papers). James M. Bowen is often cited by papers focused on Virus-based gene therapy research (29 papers), Health Systems, Economic Evaluations, Quality of Life (20 papers) and Animal Virus Infections Studies (18 papers). James M. Bowen collaborates with scholars based in United States, Canada and United Kingdom. James M. Bowen's co-authors include Daria O’Reilly, Ron Goeree, Jean‐Éric Tarride, Gord Blackhouse, Robert Hopkins, Natasha Burke, Morgan Lim, L. Dmochowski, Feng Xie and Ralph S. Freedman and has published in prestigious journals such as New England Journal of Medicine, Diabetes Care and JNCI Journal of the National Cancer Institute.

In The Last Decade

James M. Bowen

135 papers receiving 2.2k citations

Peers

Countries citing papers authored by James M. Bowen

Since Specialization

Citations

This map shows the geographic impact of James M. Bowen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Bowen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Bowen more than expected).

Fields of papers citing papers by James M. Bowen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. Bowen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Bowen. The network helps show where James M. Bowen may publish in the future.

Co-authorship network of co-authors of James M. Bowen

This figure shows the co-authorship network connecting the top 25 collaborators of James M. Bowen. A scholar is included among the top collaborators of James M. Bowen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Bowen. James M. Bowen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multicentre, single-blind randomised controlled trial comparing MyndMove neuromodulation therapy with conventional therapy in traumatic spinal cord injury: a protocol study 2020 ·BMJ Open ·Kim D. Anderson, James R. Wilson, Radha Korupolu, (unknown), James M. Bowen, Daria O’Reilly, Naaz Kapadia, Miloš R. Popović, Lehana Thabane, Kristin E. Musselman	5
2	Process mapping evaluation of medication reconciliation in academic teaching hospitals: a critical step in quality improvement 2016 ·BMJ Open ·Anne Holbrook, James M. Bowen, (unknown), (unknown), John J. You, (unknown), (unknown), (unknown), Dan Perri, (unknown), Sue Troyan, Ameen Patel	19
3	Evaluation of a chronic disease management system for the treatment and management of diabetes in primary health care practices in Ontario: an observational study. 2014 ·PubMed ·Daria O’Reilly, James M. Bowen, Rolf J. Sebaldt, (unknown), Robert Hopkins, Nazila Assasi, (unknown), (unknown), R Goeree	9
4	Systematic review of cost-effectiveness analyses of dabigatran versus warfarin for atrial fibrillation across different health care systems 2013 ·Value in Health ·(unknown), James M. Bowen, (unknown), Kaitryn Campbell, Natasha Burke, R Goeree, Anne Holbrook	0
5	The excess burden of osteoarthritis in the province of Ontario, Canada 2011 ·Arthritis & Rheumatism ·Jean‐Éric Tarride, (unknown), Daria O’Reilly, James M. Bowen, Feng Xie, Lisa Dolovich, Ron Goeree	33
6	A prospective, double-blind, randomized, controlled clinical trial comparing standard wound care with adjunctive hyperbaric oxygen therapy (HBOT) to standard wound care only for the treatment of chronic, non-healing ulcers of the lower limb in patients with diabetes mellitus: a study protocol 2011 ·Trials ·Daria O’Reilly, Ron Linden, Ludwik Fedorko, Jean‐Éric Tarride, (unknown), James M. Bowen, Ron Goeree	36
7	A review of the cost of cardiovascular disease 2009 ·Canadian Journal of Cardiology ·Jean‐Éric Tarride, Morgan Lim, Marie DesMeules, Wei Luo, Natasha Burke, Daria O’Reilly, James M. Bowen, Ron Goeree	177
8	Cost-effectiveness analysis of elective endovascular repair compared with open surgical repair of abdominal aortic aneurysms for patients at a high surgical risk: A 1-year patient-level analysis conducted in Ontario, Canada 2008 ·Journal of Vascular Surgery ·Jean‐Éric Tarride, Gord Blackhouse, (unknown), Teresa Novick, James M. Bowen, Robert Hopkins, Daria O’Reilly, Ron Goeree	38
9	Economic evaluations conducted by Canadian health technology assessment agencies: Where do we stand? 2008 ·International Journal of Technology Assessment in Health Care ·Jean‐Éric Tarride, (unknown), Morgan Lim, James M. Bowen, Gord Blackhouse, Robert Hopkins, Daria O’Reilly, Feng Xie, Ron Goeree	12
10	Effect of platelet-activating factor (PAF) on stallion sperm motility, capacitation and the acrosome reaction 2003 ·Reproduction ·(unknown), John J. Dascanio, Thomas Caceci, James M. Bowen, (unknown)	21
11	Effects of a 3beta-hydroxysteroid dehydrogenase inhibitor on monocyte-macrophage infiltration into rat corpus luteum and on apoptosis: relationship to the luteolytic action of prolactin 2000 ·Reproduction ·(unknown), James M. Bowen, P. Landis Keyes, David H. Townson	3
12	Active intralymphatic immunotherapy of uterine cervical carcinoma with viral oncolysate: a pilot study 1994 ·International Journal of Gynecological Cancer ·Ralph S. Freedman, James M. Bowen, (unknown), Creighton L. Edwards, S Wallace, E. Neely Atkinson, Constantin G. Ioannides, (unknown), (unknown), Rebecca Patenia	3
13	Viral oncolysates in patients with advanced ovarian cancer 1988 ·Gynecologic Oncology ·Ralph S. Freedman, Creighton L. Edwards, James M. Bowen, Eva Lotzová, Ruth L. Katz, (unknown), Neely Atkinson, Rita Carsetti	33
14	Code of ethics for the University of Texas System Cancer Center M.D. Anderson Hospital and Tumor Institute. 1985 ·DigitalGeorgetown (Georgetown University Library) ·Jan van Eys, James M. Bowen, (unknown), (unknown), (unknown), Stanley Reiser, C. C. Shullenberger, Andrew C. von Eschenbach	3
15	Detection of vesicular stomatitis virus (murine leukemia virus) pseudotypes by immunoelectron microscopy 1978 ·Virology ·(unknown), Douglas C. Hixson, James M. Bowen	4
16	The Current Position of A.I. in Horse Breeding* 1976 ·Equine Veterinary Journal ·W. R. Allen, James M. Bowen, (unknown), L. B. JEFFCOTT, P. D. ROSSDALE	7
17	New Japanese Rubella Vaccine: Comparative Trials 1974 ·BMJ ·J. M. Best, J E Banatvala, James M. Bowen	34
18	Progression of Hip Dysplasia in German Shepherd Dogs After Unilateral Pectineal Myotomy 1972 ·Journal of the American Veterinary Medical Association ·James M. Bowen, (unknown), S. K. Kneller, Richard Wilson, Richard A. Arnold	6
19	Artificial Insemination in the Horse 1969 ·Equine Veterinary Journal ·James M. Bowen	15
20	PUBERTY IN THE WELSH STALLION 1968 ·Reproduction ·J. D. Skinner, James M. Bowen	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact